[1]
“HR-LCMS-Guided Metabolite Profiling and Multi-Target Molecular Docking of Ruellia tuberosa L. Reveals Potential Neuroprotective Leads Against Alzheimer’s Disease”, Int. J. Res. Pharm. Sci. Technol., vol. 9, no. 3, Aug. 2026, doi: 10.33974/v5x66n28.